supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Citrus Pectin
drug:
Sorafenib
Research Papers that Mention the Interaction
“Co-administration of anti-angiogenesis agent sorafenib or bevacizumab with CL and MCP showed to cause stronger inhibition of tumor growth and metastasis than administration of each agent alone.”
Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback